Expert Discusses Challenges of Treating Individuals at Large Cancer Centers

Nov 7, 2021

Conference|NANETS Annual Multidisciplinary NET Medical Symposium

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, discusses the challenges of treating neuroendocrine tumors in large cancer centers.

In a Pharmacy Times® interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.

She discussed the challenges of treating NETs in large cancer centers.

Related Videos

Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com

Biosimilars | Image credit: lexiconimages - stock.adobe.com

Medical care team | Image credit: Iryna - stock.adobe.com

Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com

Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com

Medical science laboratory | Image credit: alphaspirit - stock.adobe.com

Gastroenterologist using digital x-ray of human intestine holographic scan projection 3D rendering | Image Credit: sdecoret - stock.adobe.com

Pharmacist managing inventory | Image credit: StratfordProductions - stock.adobe.com

Related Content

Early Clinical Data for Combination of Fianlimab, Cemiplimab Shows Clinically Meaningful Results in Advanced Melanoma

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

Medication Acquisition Programs Can Improve Access to Treatment

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

Improving Patient Outcomes Starts With Patient Trust in Health Care, Pharmacists

Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

Early Clinical Data for Combination of Fianlimab, Cemiplimab Shows Clinically Meaningful Results in Advanced Melanoma

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

Medication Acquisition Programs Can Improve Access to Treatment

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

Improving Patient Outcomes Starts With Patient Trust in Health Care, Pharmacists

Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

Early Clinical Data for Combination of Fianlimab, Cemiplimab Shows Clinically Meaningful Results in Advanced Melanoma

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

Medication Acquisition Programs Can Improve Access to Treatment

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

Improving Patient Outcomes Starts With Patient Trust in Health Care, Pharmacists

Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

Related Content

Dermatologist examining moles of patient in clinic | Image Credit: Pixel-Shot - stock.adobe.com

Early Clinical Data for Combination of Fianlimab, Cemiplimab Shows Clinically Meaningful Results in Advanced Melanoma

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

Pharmacy Focus: Independent Rx Forum- What to Know for the NCPA 2022 Annual Convention

Credit: Prostock-studio - stock.adobe.com.

Medication Acquisition Programs Can Improve Access to Treatment

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

Pharmacy Focus: On The Shelf - Camille Schrier, 2019 and 2020 Miss America

Credit: Prostock-studio - stock.adobe.com.

Improving Patient Outcomes Starts With Patient Trust in Health Care, Pharmacists

Credit: Dr_Microbe - stock.adobe.com

Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.